跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 65,746 条关于
“mantle-cell lymphoma”
全部
65,746
临床试验
48,661
药物
4,583
机构
173
资讯
12,329
去年
Acalabrutinib Receives FDA Approval for Previously Untreated Mantle Cell Lymphoma
去年
FDA Grants Priority Review to Calquence for Untreated Mantle Cell Lymphoma
去年
Sonrotoclax Plus Zanubrutinib Shows Promise in Relapsed/Refractory Mantle Cell Lymphoma with 78% Response Rate
2年前
CALQUENCE Plus Chemoimmunotherapy Shows 27% Reduction in Disease Progression Risk for Untreated Mantle Cell Lymphoma
去年
Dual-Targeted CAR T-Cell Therapy Shows 100% Response Rate in Relapsed/Refractory Mantle Cell Lymphoma
去年
Acalabrutinib Regimen Shows Promise in Untreated Mantle Cell Lymphoma
9个月前
Bristol Myers Squibb Receives European Commission Approval for Breyanzi in Relapsed/Refractory Mantle Cell Lymphoma
去年
Promising Pipeline for Mantle Cell Lymphoma Treatment: 22+ Therapies Under Development by 20+ Companies
去年
Galapagos Receives FDA RMAT Designation for CAR-T Therapy GLPG5101 in Relapsed/Refractory Mantle Cell Lymphoma
去年
EMA to Review Ibrutinib for Frontline Mantle Cell Lymphoma in Transplant-Eligible Patients
第 1 页,共 1233 页
上一页
下一页